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located primarily in the RV outflow tract and anterior RV.But, SEA for LVAR-
VOT were located moatly in two areas along the lateral RV base. Although
locations differed, the PGs measured at the SEA were of low magnitude and
were not significantly different between configurations (LVARVOT7.1 + 4.2
V/cm, LVASVC7.4+ 3.0 V/cm).
The locations of SEA leading to VF for sub-threshold DF shocks depend
upon the DF electrode configuration. Regardless of the configuration, SEA
are located where the PG is low and of a similar magnitude. These results
support the upper limit of vulnerability hypothesis for DF.
m1046131 Where is the Best Alternste Implantation Site of
the “Hot Can” Electrode?
Y. Yamanouchi, K.A. Mowrey, D.G. Hills, M.J. Niebauer, P.J.Tchou,
B.L. Wilkoff. Cleveland Clinic Foundation, C/eve/and, OH, USA
The “hot can” (RV to prepectorel ICD) lead system has been shown to defib-
rillate efficiently. A “can” electrode is implanted in the left pectoral site in most
patients. However, in some patients it is impossible or inconvenient to implant
at such a site. Therefore, the purpoiie of this study was to evaluate relative
efficacy of alternative sites for the “hot can” electrode. Methods: Defibrillation
thresholds (DFTs)were evaluated with a “hot can” system in random order
in 7 pigs (34 + 3.6 kg) using five different “can” electrode implantation sites:
right pectoral, left pectoral; left exillary, right upper abdomen and left upper
abdomen. A right ventricular coil was the cathode for the first-phase of the
biphaeic waveform (135 vF, 65/65% tilt) and the DFT wee determined by a
“down-up down-up” protocol. Results: Mean stored energy (joules) at DFT is
ahown in the table below for each “can” electrode aite.
Imdsntationsite of a “hotcan”electrode
Rightpectoral Left pectoral Leftaxillary Rightabdomen Leftabdomen
20.3 & 2.7” 15.9 & 3.8 14.9 + 2.5 32.0 k 3.4** 30.0 * 3.4**
*p <0.01, **p <0.0001 vs left pectoraland left submaxillaryaite.
Conclusions: 1) DFT is depend upon the “hot can” implantation site. 2)
DFT energy waa unchanged in the axilla~ site and 30% increased with right
pectoral placemant. 3) DFT’s for abdominal “hot can” to RV are inferior to
&ctorally placement ICDS.
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m1047141 PET Myocardial Perfusion Imaging SignificantlyRedu~s the Coet of Coronary Diseese
Management
M. Merhige, G. Stem, D. Saiki, T. Houston, V. Shelton. SUNYati3uffa/o,
Buffalo, IW USA
We hypothesized that myocerdial perfusion imaging (MPI) with PET and Rb-
B2resulta in coatsavings incoronafydisease (CAD) management, compared
with SPECT MPI, due to improved test accuracy, ,despite the increased
coat of PET. Accordingly, we compared procedure Costaand outcome8 in
303 sequential patients referred for CAD evaluation with PET MPI, and in
102 patients imaged with SPECT, matched for pretest likelihood of disease
with “CADENZA” aoftware, which incorporate type of chest pain, cardiac
riak factors, comorbid conditions, and previous exerciae test results. Costs
were calculated ueing estimated chargea: SPECT-$1000, PET-$1850,Angio-
$5000, PTCA-$1O,OOO,CABG-$40,000. At least thrae month follow up wee
obtainad in all patients.
There were no deaths in the PET group. One myocardial infarction oc-
curred just prior to angiography, which waa recommended due to a high risk
PET result.
The percentages of angiogrephy, CABG and PTCI for SPECT vs. PET
were: 32.3 va 9.6; 7.8 vs 3.3; and 2.0 vs 1.7 respectively.
n Pretest Probability DiagnosticCoaWl Treatment Cost@f TotalCostFl
SPECT 102 0.38+ 0.14 $2,617.65
PET
$3,333.33 $5,950.96
303 0.37 + 0.17 $2,380.07 $1,724.48 $4,104.55
Conclusion: A management strategy uaing PET-Ml in patients with an in-
termediate risk of CAD results in: reduced angiography and revascularization
procedures, excellent short-term patient outcomea, and a 30% cost-savings
when compared to conventional management with SPECT imaging.
H1047142 SimulteneouaMyocardialBlood Flow Estimation
Using 13N-NH3-PET end the Argon Inert Gas
Technique in Humsne
J. Kotzerke, S. Glafz, G. Glatfing, M. Hoherl, P.Weismullerl,
V. Hombach 1, S.N. Reske. Nuk/ear-medizin, Universikif U/m, Germany
1Inner’sMedizin, Urriversiklt U/m, Germany
Purpose of the study wee to validate the quantification of myocerdial blood
flow (MBF) with 13N-NH3 and positron emission tomography (PET) with
the argon (Ar) ineti gas methode. Estimation of MBF using NH3-PET and
the application of a two compartmental model was validated in animals
using 15H-H20 PET and the microsphere technique. In humans, calculated
values uaing this approach seemed to be reasonable but were not validated.
We investigated 12 patienta (7 male, 5 female) who had undergone
coronary angiography (relevant coronaty stenosea were excluded) and were
suspicious for small vessel disease. MBF waa aimulteneous eeaesaad after
injection of 740+ 110MBq 13N-NH3 using dynamic PET (ECAT931 or ECAT
Exact HR+) and by the argon (Ar) inerf gas method. Meeeurementa were
performed at rest and during vasodilatation (0.80 mg/kg/4 reins diypridamole
or 0.14 mgikg/min adenosine for 15 reins).
In 21 investigations (9 stress, 12 rest) estimation of MBF were successful
for both modalities: flow valuea were 0.98 + 0.16 ml/g/min and 0.90+ 0.24
ml/g/min at rest and 2.23 + 0.97 mlfg/min and 2.32 + 0.73 ml/g/min during
vasodilatation for Ar and PET, respectively.These values are atatisticslly not
different (pairad t test: p=- 0.05). Correlation of both methods was r = 0.a9.
High MBF during rest was due to increased breathing work and excitation
(suspected from a rate pressure product of 9.426 + 2.149). Coronary flow
reserve was 2.3 + 0.9 and 2.9 + 1.4 for Ar and PET, respectively.
For the first time in vivo MBF estimation using NH3-PET and a two com-
partment model was validated with the argon inert gas method in humans.
1047-143 PredictiveVslueof PETBloodFlow/Meteboiiem
Miemstch in Patiente with Type II Diabetes
Mellitus
H. Sch6der, R. Campisi, T. Ohtake, D.H. Moon, C.K. Hoh, J. Czernin,
H.R. Schelbert. UCLA Schcmlof Medicine, Los Angeles, CA, USA
The accuracy of PET blood flow/glucose metabolism imaging for predicting
the pos.trevascularizationimprovement in regional LV function in CAD pe-
tients ranges from 72-MY. in Unselected patients, yet remaina undefined
in those with diabetes mellitus (DM). Therefore, we studied 20 consecutive
patients (mean age 64 + 11 yeara; 8 with DM = group 1; 12 without DM =
group 11)with PET ‘3N-ammonia and ‘aFDG 2 + 2 weeks prior to revascu-
Iarization. Tha LVEF did not differ between both groups (35 + 8Y0 vs. 29
* 7YO),Flow/meta~lism mismatches in the LAD, LCX and RCA te~toriea
were identified by polar map analysis. Regional and global LV function was
determined by 2D echocerdiography 14 + 14 days prior to and 150 + 145
days after revaacularization. Changes in regional wall motion by ? 1 grade
on a acele of 4 (O= akinesis and 3 = normal) were considered significant.
Fifty-two territories were analyzed; 23 were classified as mismatch, 13 se
match and 16 as normal.
Presence of mismatchand improvementin regionalLVfunction
Sena Spac PPV NPV Acc
GrouDI 92”h 63% so% S3% Sl%
GrouL II 38”/4 S7% 50% 80% 74%
LVEF increased from 29 + 6% to 40 + 7% (p c 0.01) in patients with
z 2 mismatch territories but not in patients with only one mismatch terrftoty
(34 k 11% vs. 36+ 10%, p = 0.5). Thus, if ? 2 mismatch territories were
conaiderad a prerequisite for an improvement in LVEF by at Ieaat 5%, the
positive and negative predictive values were 60% and 100% in group I and
67% and 72% in group Il. In conclusion, the predictive accuracy of pET
blood flow/metabolism imaging is maintained in patients with DM. Moreover,
regulation of glucose utilization in reversibly injured myocardium appears to
be presemd by local factors despite insulin resistance.
I 1047-1441 The MeesurementofMYOcardial B,00dFIOw
With Positron Emission Tomography is Highly
Reproducible
R. Lorenzoni, R. Giatri, S.D. Rosen, P.G.Camici. Hammersmith Hospital,
Londorr, UK, CNR /nstitute of Clinical Pfrysio/ogy,Pisa, /ta/y
Positron emission tomography (PET) is considered the gold atandard for the
non-invasive quantification of myocardial blood flow (MBF) in man. However,
aince little is known about the reproducibility of MBF measurements with PET,
we aimed to study baseline and hyperemic MBF twice in the same patients
on two different occasions. Methods: Thirty patients with angiographically
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normal corona~ arteries were studied; 14 pts with cardiac syndrome X
(5X, 9 F, age 52 + 7 yeare) and 16 pts with hypertrophic cardiomyopathy
(HCM, 4 F, age 41 &12 years). The clinical status of all pts was unchanged
between the two PET studies. The MBF tracer was 015-water for 5X and
NIS-ammonia for HCM. MBF (mllminfg) was measured at baseline (baa)
and after dipyridamole (dip; 0.56 mgkg in 4 rein) and the CVR computed as
dipMBF/besMBF (absolute units). The coefficient of variation (CV%) of MBF
wea calculated as SD/mean of regional basMBF and dipMBF. Results: Mean
time between studies was 216 days, range 10-662, for 5X and 641 days,
range 36-1765, for HCM. No differences were found between the first and
aemnd study in SX and HCM for measured and derived MBF parameters
(ANOVA, p = NS: table).
SX Ist study SX2ndstudy HCMISt StUdy HCM 2nd study
basMBF 1.16+0.41 1.20 + 0.26 0.6440.27 0.76 + 0.31
dlpMSF 3.11 + 1.08 3.85+ 1.13 1.35 i 0.47 1.40 + 0.69
CVR 2.71 +0.63 3.08+ 0.80 1.68 * 0.54 1.84 + 0.69
bsscv 16+9 16*8 13*9 14*9
dlpCV 27& 13 21 *7 17* 12 16+9
Corrc/usions:The results of the present study show that PET offers repro-
ducible non-invasive measurements of MBF in humans.
m1047145 Effectsof LeftBundleBranchBlockonCardiacPETImaging
P.Zanm,, F.Chierichetti, S. Cargnel, A. Fini, G. Ferlin. Pet Centec
Caste/franco Veneto, Italy
To evaluate the effects of left bundle branch block (LBBB) on perfusion and
metabolic cardiac PET imaging, 20 patients (16 M,2 F,aged 51-74 yra, mean
64) affected byperrnanent, complete LBBBwereenrolled and submitted to: 1)
glucose load F18-fluorodeoxiglucose PET(FDG-PET); 2) rest N13-ammonia
PET (NH3-PET); 3) coronary angiography; 4) echocerdiography. Eleven pts
presented a history of a previous myocerdial infarction, anterior in focalization
in 4 and infero-posterior in the other 7 at the echocardiography.The other 9
pts presented a left ventricular dilatation, without signs of previous necrosis.
At the mronary angiogrephy 12 pts presented a significant stenosis of LAD,
8 of these with involvement of other coronaries, while 2 pts presented only
stenoses in RCA and LCX and in the other 6 pts no significant coronaty
stenosis was found. At the FDG-PET all the LBBB pts presented a severe
uptake defect (< 50% of the maximum) in the septum, extending to nearby
regions of the anterior and inferior left ventricular wall, overall involving from
40 to 60% of the ventricle wall. In the corresponding area the perfusion,
evaluated by NH3-PET, was presewed. At the echocardiography tha wall
motion segmental analysis revealed no significant correlation between the
dysfunctional area and the site of the FDG uptake defect.
In mnclusion our study could suggest that: 1) in Lr3BBa change in the
metabolic activity of the septum without damage in perfusion was present; 2)
this was evident also in the ptawithout LAD stenosis; 3) in LBBBptsaviability
study using FDG-PET may overestimate the extension of the necrosis, to
avoid this misinterpretation it appears advisable to perform a perfusion PET
study using N13-NH3 as well.
1047-146 DeieyedFDGimagingImproves
Myocardial/BloodPoolContrast
G. Srinivaaan, S.L. Bacharach, A.N. Kitsiou, K.A. Nour, C.M. Davis,
V. Dilsizian. National Institutes of Hea/th, Bethesda, MD, USA
In some pte with CAD, imaging of the myocerdium with F-18 deoxygiucose
(FDG) at 30-80 min post injection by PET produces images with Iowcontrast
between myocardium and blood pool. We hypothesized that imaging at
a later time might improve the quality of FDG images both by increasing
myocerdial uptake and clearance of FDG from the blood. We tested this
hypothesis in 7 pts with CAD: 6 men, 1 woman, age 66 + 11; 3 diabetics.
PET images were acquired both at 30-60 min post injection of 57-10 mCi
of FDG (1 hr after glucose load) and at 135-165 min. For each pt, the
antire LV was divided into 41 approximately equal segments. Both absolute
(nCi/ccimCi) and normalized (to peak thallium activity on stress) FDG uptake
were analyzed. All data were decay correctedto time of injection. Normalized
early and late FDG values were highly correlated (slope = 1.26, intercept =
-0.25, r = 0.92, SEE= 0.05), implying eariy and late images provide similar
clinical information. Of215 segments, 206 (97%) were cancoru’antforviability
between early and late imaging. Myocardial FDG uptake increased on late
imaging (77 + 27 early vs 116 + 57 late, p < 0.05). In all pta, late imaging
wa8 associated with decreased blood pool activity (34+ 6.6 early vs 18 + 7.1
late, p < 0.01), resulting in improved late myocardium/blood pool contrast
ratio (2.3 early va 7.1 late, p < 0.01). This improvement in myocerdial
contrast was similar for diabetics (from 2.1 to 6.5) and non diabetics (from
2.5 to 7.6), and was consistent with marked visual improvement, These data
suggest that despite a slight decrease in myocerdial counts due to decay,
the increased myocardial FDG uptake combined with decreased blood pool
activity improves late image quality. The good early-late FDG correlation
suggests that the improvement does not alter the FDG distribution in a
clinically significant way, but this needs to be verified in a larger number of
pts.
PY] Predi.tivaVaiueof FDGimaginginPatientaVifith
Chronic iachaemic Left Ventricular Dysfunction
Enrolled in a Prospective European Muiticentre
Viability Study
F. Fath-Ordoubadi. EEC CorrcertedAction on Positron Emission
Tornograpfry(PET) kwestigation of Ce//u/arr?egerteration and
Degeneration, London, UK, Louvain, B, Lyon, France, Groningen, NL,
Li&a, B, Turku,SE Copenhagen, Denmark, Germany
Aim of this study was to ascertain the value of quantitative PET with 1SF-
fluorodeoxyglucose (FDG) to identify hibernating myocardium. A total of 502
patients (pts) with at least one dysfunctional (D) segment (S) subtended by a
stenotic coronary artery amenable to revascularization (R) were enrolled over
2 years. Left ventricular (LV) function was assessed before and 4-6 months
after R by radionuciide ventriculography or echocarciiogrephy. To maximize
myocardial FDG uptake and overcome insulin resistance, all studies were
performed during euglycemic hyperinsulinemic clamp (EHC). A total of 254
pts have undergone R, by angioplasty (14%) or bypass. Complete follow up
data on 121 pts (age 59 + 9) who had R are available: LV ejection fraction
(EF) was 37 + 13% before and 40 + 15% after R (p < 0.01); the ragional
wall motion score (1 = normal; 2 = hypokinetic; 3 = akinetic; 4 = dyskinatic)
was 2.0 + 0.6 before and 1.7 + 0.6 after R (p < 0.001). A total of 326 S
were normal (N) and 382 D. After R, 204 (53%) D-S improved (IMP), 149
(39%) were unchanged (UNC) and 29 (6%) worsened. The Metabolic Rate
of Glucose (MRG; &mol/min/g; lump constant = 1) was 0.42 + 0.18. in N-S,
0.36 + 0.17 in IMP-S (p <0.01 vs N) and 0.31 + 0.17 in UNC-S (p <0.01
vs N and IMP). /n conclusion, these interim results indicate that FDG-PET
during EHC can provide the quantitative assessment of myocardial viability
in the absence of perfusion measurement.
_ MyoCardiS,BIOodFioWchan~eaDuringLoW
Dose Dobutamine Infusion: Relation to F-18
Daoxygiucose Uptake
A.N. Kitsiou, S.L. Bacharach, C.M. Davis, G. Srinivasan, K.A. Nour,
A.A. Quyyumi, V. Dilsizian. National krstitutes oflfeakh, Bathesda, MD, USA
In asynergic myocardial regions rendered dysfunctional by chronic hypop-
erfusion, F-18 deoxyglucose (FDG) is useful in differentiating viable from
scarred myocardium. In this study, we determined whether regional myocer-
dial blood flow (MBF) res~nse during low dose dobutamine (LDD) infusion
also differentiates hypoperfused but viable from scarred myocardium when
compared to FDG uptake. To this end, 11 pts (mean age 65 + 9 years)
with chronic CAD and LV dysfunction (mean LVEF = 32 + 6%) underwent
positron emission tomography (PET) with N-13 ammonia (NHJ and FOG.
Absolute MBF was mmputed at rest and during LDD (5 #g/kg/rein) infusion,
using a two compartment NH3 model. Four to five NH3 and FDG PET slicea
(8 regions per slice) were matched and analyzed for each patient. Rest and
LDD N-13 ammonia data were then analyzed according to the magnitude of
FDG uptake.
FOG (% uptake) N-13 Ammonia (ml/min/g)
Reat Low-doaeDobutsmirw
Normal (> so%) 0.64 * 0.1s 0.96 + 0.32
At rest, MBFwas similar in regions with moderately and severely reduced
FDG uptake. During LDD infusion, although mean MBF increased in all three
categories, the extent of MBF increase was significantly greater in regions
with moderately than in regions with severely reduced FDG uptake (0.35 +
0.26 vs 0.20 + 0.30 ml/min/g, p c 0.05). Furthermore, 85% of regions with
moderately reduced FDG uptake showed mismatch pattern (FDG: MBF >
110).These data suggest that an assessment of MBF response during LDD
infusion may differentiate hypoperfused but viable from nonviable myocardial
regions.
